Understanding the link between gut health and psoriasis opens new avenues for treatment and highlights the need for comprehensive care approaches that encompass both dermatological and gastrointestina ...

AbbVie (ABBV), a large drug maker, is jumping 8% after the company provided significantly higher-than-expected 2025 earnings per share guidance this morning.

In this large prospective cohort study (n=497 567), rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis ... including the use of nonsteroidal anti‐inflammatory drugs, disease‐modifying ...

Background Upadacitinib is a Janus kinase inhibitor under evaluation for the treatment of psoriatic arthritis (PsA ... Stable background treatment of non-steroidal anti-inflammatory drugs, ...

Potashman and colleagues sought to investigate the association between PD incidence and immunosuppressive anti-inflammatory drugs in individuals diagnosed with rheumatoid arthritis, ulcerative ...

Psoriasis is a chronic skin disease that manifests itself mainly with skin symptoms (dryness, itching, scaly skin, abnormal ...

AbbVie's strong earnings and growth projections make it a solid buy for 2025, with no major patent expirations until 2030. Learn more on ABBV stock here.

regionh.dk Objective To evaluate risankizumab, a biological therapy that inhibits interleukin 23, in patients with active psoriatic arthritis (PsA ... First-line PsA treatment includes non-steroidal ...